1.前言本文介绍的药物绝大部分已上市或在进一步的人体试验中。在这一报中首次报道了X线造影剂方面的进展。鉴于各领域的发展都相当广泛,β-内酰胺抗生素方面尤其如此,故只能对个别重点品种加以阐述。从其它类别抗生素发展起来的新化合物因治疗意义甚小而被略去。用于预防和治疗寄生虫病(疟疾)的新药,因对它的归类尚有异议,所以与15报一样附在最后。 2.主要作用于中枢神经系统的药物 2.1精神抑制药对作用时间极长的抗精神病药的评价仍 1. Introduction The vast majority of the drugs described in this article are on the market or in further human trials. The first report in this paper on the progress of X-ray contrast agents. Given the wide range of developments in various fields, especially in the case of β-lactam antibiotics, only individual priority species can be elaborated. New compounds developed from other classes of antibiotics are omitted for therapeutic reasons. New drugs used for the prevention and treatment of parasitic diseases (malaria) have objections to its classification and are therefore attached at the end of the report. 2. The main role in the central nervous system drugs 2.1 antipsychotics long-acting antipsychotic evaluation is still